Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
CNTA Analyst Ratings
Moderate Buy
3 Buy
7 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CNTA Stock 12 Month Forecast
Average Price Target
$45.00
▲(13.38% Upside)
| Highest Price Target$62.00 | Average Price Target$45.00 | Lowest Price Target$38.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Leerink Partners
$40
Hold
0.78%
Upside
Downgraded
04/01/26
Guggenheim
―
Hold
―
Downgraded
04/01/26
LifeSci Capital
―
Hold
―
Downgraded
04/01/26
Needham
―
Hold
―
Downgraded
03/31/26
Wolfe Research
―
Hold
―
Downgraded
03/31/26
Stephens
$35→$47
Hold
18.42%
Upside
Downgraded
03/31/26
B. Riley Securities
$45
Hold
13.38%
Upside
Downgraded
03/31/26
Truist Financial
$33→$38
Buy
-4.26%
Downside
Reiterated
01/29/26
Piper Sandler
$38
Buy
-4.26%
Downside
Reiterated
01/16/26
Oppenheimer
$62
Buy
56.21%
Upside
Reiterated
01/15/26
Wells Fargo
$35
Buy
-11.82%
Downside
Reiterated
12/17/25
Jefferies
$27→$30
Buy
-24.41%
Downside
Reiterated
11/13/25
Morgan Stanley
$27
Buy
-31.97%
Downside
Reiterated
11/12/25
Evercore ISI
―
Buy
―
Reiterated
09/03/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Leerink Partners
$40
Hold
0.78%
Upside
Downgraded
04/01/26
Guggenheim
―
Hold
―
Downgraded
04/01/26
LifeSci Capital
―
Hold
―
Downgraded
04/01/26
Needham
―
Hold
―
Downgraded
03/31/26
Wolfe Research
―
Hold
―
Downgraded
03/31/26
Stephens
$35→$47
Hold
18.42%
Upside
Downgraded
03/31/26
B. Riley Securities
$45
Hold
13.38%
Upside
Downgraded
03/31/26
Truist Financial
$33→$38
Buy
-4.26%
Downside
Reiterated
01/29/26
Piper Sandler
$38
Buy
-4.26%
Downside
Reiterated
01/16/26
Oppenheimer
$62
Buy
56.21%
Upside
Reiterated
01/15/26
Wells Fargo
$35
Buy
-11.82%
Downside
Reiterated
12/17/25
Jefferies
$27→$30
Buy
-24.41%
Downside
Reiterated
11/13/25
Morgan Stanley
$27
Buy
-31.97%
Downside
Reiterated
11/12/25
Evercore ISI
―
Buy
―
Reiterated
09/03/25
Best Analysts Covering Centessa Pharmaceuticals
3 Months
xxx
Success Rate
6/6 ratings generated profit
Average Return
+26.70%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +26.70% per trade.
1 Year
2 Years
xxx
Success Rate
7/7 ratings generated profit
Average Return
+72.81%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +72.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CNTA Analyst Recommendation Trends
Rating
Dec 25
Jan 26
Feb 26
Mar 26
Apr 26
Strong Buy
10
13
8
6
1
Buy
14
13
6
2
4
Hold
1
19
26
29
22
Sell
0
4
6
6
2
Strong Sell
0
0
0
0
0
total
25
49
46
43
29
Each month's total comprises the sum of three months' worth of ratings.
CNTA Financial Forecast
CNTA Stock Forecast FAQ
What is CNTA’s average 12-month price target, according to analysts?
Based on analyst ratings, Centessa Pharmaceuticals’s 12-month average price target is 45.00.
What is CNTA’s upside potential, based on the analysts’ average price target?
Centessa Pharmaceuticals has 13.38% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CNTA a Buy, Sell or Hold?
Centessa Pharmaceuticals has a consensus rating of Moderate Buy which is based on 3 buy ratings, 7 hold ratings and 0 sell ratings.
What is Centessa Pharmaceuticals’s price target?
The average price target for Centessa Pharmaceuticals is 45.00. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $62.00 ,the lowest forecast is $38.00. The average price target represents 13.38% Increase from the current price of $39.69.
The highest analyst price target is $62.00 ,the lowest forecast is $38.00. The average price target represents 13.38% Increase from the current price of $39.69.
What do analysts say about Centessa Pharmaceuticals?
Centessa Pharmaceuticals’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of CNTA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.